BD Medical, a US-based medical technology company, has launched BD Neopak, a new glass prefillable syringe system that is designed for the administration of biopharmaceutical injectable drugs.
The injectable syringe offers high quality and device integration to the biopharmaceutical companies and patients.
It is manufactured in a completely indexed process, which eliminates glass-to-glass contact, leading to in fewer visual defects and increased glass strength.
The new process also lessens the silicone levels while simultaneously maintaining the right glide force functionality. With tighter dimensional tolerances and by limiting the dead volume space, the BD Neopak Glass Prefillable Syringe also reduces waste and overfilling of the biologic drug.
BD Medical Pharmaceutical Systems president Claude Dartiguelongue said, "The BD Neopak™ Glass Prefillable Syringe is designed to reduce risks associated with primary container and drug interactions and enable our customers’ drug products speed to market safely and effectively."